SEDAJECT™ & ATAJECT™
Sedative - Analgesic and Reversing Agent for Companion Animals.
SEDAJECT™
(Dexmedetomidine hydrochloride injection, 0.5 mg/ml)
Veterinary Use Only
Sedative and analgesic
For IM or IV administration in dogs and cats
Indications:
- Sedative and analgesic in dogs and cats to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures.
- Also indicated for use as a preanesthetic to general anesthesia in dogs and cats.
ATAJECT™
(Atipamezole hydrochloride injection, 5.0 mg/ml)
Veterinary Use Only
Dexmedetomidine and Medetomidine Reversing Agent
For IM administration in dogs
Indications:
- Indicated for the reversal of the clinical effects of the sedative and analgesic agents dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.
SEDAJECT™ & ATAJECT™
SEDAJECT™ and ATAJECT™ were developed by Vetpharma Animal Health S.L. and are manufactured in Spain. Both products are sold in over ten countries in Europe including Spain, France and Belgium.
Grey Wolf Animal Health is proud to be the Canadian distributor of Vetpharma Animal Health S.L.
References
1. Kaur, M., & Singh, P. M. (2011). Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesthesia, essays and researches, 5(2), 128–133. https://doi.org/10.4103/0259-1162.94750
